Regulation of post-translational modification of PD-L1 and associated opportunities for novel small-molecule therapeutics-Reference-Cited by-同舟云学术

Regulation of post-translational modification of PD-L1 and associated opportunities for novel small-molecule therapeutics

Published:2024-07 Issue:15 Volume:16 Page:1583-1599
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Tang Jinglin¹,Liu Han¹,Li Jinze¹,Zhang Yibo¹,Yao Suyang¹,Yang Kan¹²,You Zhihao¹,Qiao Xiaoqiang¹²,Song Yali¹³^ORCID

Affiliation:

1. Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University, Baoding, Hebei 071002, China

2. Key Laboratory of Medicinal Chemistry & Molecular Diagnosis, Ministry of Education, Hebei University, Baoding, Hebei 071002, China

3. State Key Laboratory of New Pharmaceutical Preparations & Excipients, Hebei University, Baoding, Hebei 071002, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hebei Province

Undergraduate Innovation and Entrepreneurship Training Program of Hebei Province

Natural Science Foundation of Science and Technology Project of Hebei Education Department

Innovation Team Project of Hebei University

Natural Science Interdisciplinary Research Program of Hebei University

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17568919.2024.2366146

Reference98 articles.

1. The Immunological Synapse: A Molecular Machine Controlling T Cell Activation

2. Three-dimensional segregation of supramolecular activation clusters in T cells

3. Dynamic regulation of T cell activation and co-stimulation through TCR-microclusters

4. Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

5. PD-1/PD-L1 pathway inhibitors in advanced prostate cancer